Genmab A/S announced further transactions under its ongoing share buy-back program, which was initiated on March 25, 2025. The reported transactions occurred from March 31 to April 4, 2025.
Following these latest transactions, Genmab holds 3,165,695 shares as treasury shares. This represents 4.78% of the company's total share capital and voting rights.
The share buy-back program is scheduled to be completed no later than July 10, 2025. It is being conducted in accordance with Regulation (EU) No. 596/2014 and the Commission Delegated Regulation (EU) 2016/1052, known as the 'Safe Harbour Regulation'.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.